Back to Journals » Drug Design, Development and Therapy » Volume 8

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Total article views   HTML views PDF downloads Totals
14,359 Dovepress* 13,725+ 1,227 14,952
PubMed Central* 634 191 825
Totals 14,359 1,418 15,777
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar